FDA
approval
· 2017-06-17
FDA Approved: AMNESTEEM — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
FDA approved a supplemental ANDA for AMNESTEEM (isotretinoin) from Mylan Pharmaceuticals. This approval confirms a generic version of the brand drug is now avai…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMNESTEEM (ISOTRETINOIN)